Pro-urokinase (pro-uPA) and activated uPA are confined to focal adhesions and d-cell contacts. We studied the distribution of the uPA receptor (uPAR) on human fibroblasts (HES) and rhabdomyosarcoma (RD) cells by immunofluorescence and immunoel-n miampy. Two monaclonal antibodies (MAb) utilized were against uPAR: MAb R4, which reacts with occupied and unoccupied uPAR, was concentrated at focal adhesions; MAb R3 reacting with unoccupied receptor stained cell surfaces diffusely. MAb R4 stained cell-cell contacts, tips of microspikes, and CO-localized with vinculin. Of the matrix and integrin components tested, a& integrin was found at focal adhesions but more centrally than uPAR. Since uPAR is anchored to the plasma membrane through
Introduction
There is extensive evidence that hydrolytic enzymes are involved in both cell invasion and tissue-destructive. processes (1) (2) (3) (4) . Urokinase plasminogen activator (uPA) and its cell surface receptor (uPAR) are key molecules for initiation of the plasminogen activation cascade, a major pathway of extracellular proteolysis. Urokinase, a serine protease, can convert the widely occurring zymogen plasminogen to enzymatically active plasmin (1) (2) (3) (4) . Plasmin can directly degrade various extracellular matrix proteins (5) and activate other matrix-degrading enzymes such as procollagenases (6,7) and latent growth factors such as transforming growth factor p ('R3F-P) (8) .
Urokinase secretion has been described for a number of normal and malignant cell types (1.9-11). It is secreted as an inactive singlechain pro-enzyme (pro-uPA) (12) (13) (14) (15) and is converted at the cell surface to its active two-chain form (15) (16) (17) . A large body of evidence indicates that uPA-catalyzed plasminogen activation is related 41: [1291] [1292] [1293] [1294] [1295] [1296] [1297] [1298] [1299] [1300] [1301] 1993) to the invasive cell phenotype (18) (19) (20) (21) (22) (23) (24) (25) (26) . uPA is a strong prognostic marker for progressive breast cancer (27.28).
Monocytes and monocyte-like U-937 cells were the first cells shown to possess a specific binding site for active uPA and pro-uPA (29). The uPAR molecule has recently been characterized, cloned, and sequenced (30-33). It is linked to the plasma membrane through a GPI anchor and thus lacks a cytoplasmic domain (34). The amino acid sequence of uPAR consists of three homologous repeats, the NH2-terminal one of which contains the ligandbinding site (35). For the two other domains no specific ligand is known. Both the single-chain pro-uPA and the active two-chain uPA bind to uPAR. Concomitant binding of pro-uPA to uPAR and plasminogen to as yet unidentified sites at cell surfaces strongly enhances plasminogen activation (15, 17, 36) . Cloning and sequencing of the monocyte activation antigen Mo3 have shown its identity to uPAR (37).
Preliminary experiments have suggested that plasminogen activators may themselves function as motility factors. Mechanical wounding of endothelial cell layers increases uPA activity, and when cell movement stops uPA activity falls back to the basic level (38).
Recent studies on uPA and uPAR with U-937 and HL60 cells suggest that adhesion of these cells depends on the uPA-uPAR complexes formed on the cell surface (39). Previous studies have also 1291 suggested that migration of human keratinocytes, neutrophils, and bovine capillary endothelial cells is promoted by occupancy of uPAR, yet without a requirement for catalytic uPA activity (40-42).
Pro-uPA, active uPA, and uPA-catalyzed plasminogen activation have recently been localized to the cell-substratum and cell-cell contact sites. Urokinase was found at focal adhesions, cell-cell contacts, and at the tips of microspikes of adherent human cells in culture (43-46). Of the three well-known forms of cell contacts, i.e., focal adhesions, close contacts (47-49), and fibronexus structures (50), uPA was found only in focal adhesions. The cytoplasmic side of focal adhesions contains d i n and vinculin as well as a-actinin and terminating actin filaments. Certain integrins such as the a433 vitronectin receptor and certain sulfated proteoglycans, which are integral membrane components, link the plasma membrane to the pericellular matrix at these sites (51).
A wide variety of proteins are anchored to the plasma membrane by GPI lipid (52,53); many are distributed in a diffuse or clustered pattern at the apical surface of epithelial cells (54-56).
Since uPA has a restricted distribution on the ventral cell surface (43-45), in the present study we localized GPI-anchored uPAR on the cell surface by use of recently developed monoclonal antibodies (MAb) (36). We show that unoccupied and occupied uPA receptors have different distributions and we also demonstrate that unoccupied uPAR is mobile in the plane of the plasma membrane.
Materials and Methods

Cells. Human rhabdomyosarcoma (RD) cells were from the American
Type Culture Collection (CCL 136; Rockville, MD). Cultures of human embryonic skin fibroblasts (HES) were established with standard methods. The cells were grown in 1.9-cm2 culture wells (Nunc; Roskilde, Denmark) on glass coverslips in Eagle's minimal essential medium (MEM) supplemented with 8% fetal calf serum (FCS) Gibco; Grand Island, NY), 2 mM L-glutamine, 100 IUlml penicillin, and 100 yglml streptomycin.
Antibodies. Purified mouse MAb against human uPA (clone 12) (43, 45, 57) and hybridoma culture supernatants of clone R4 and clone R3 MAb against human uPAR (36,58,59) were used. MAb R4 reacts with the nonuPA-binding COOH-terminal two thirds of the uPAR molecule (36, 58, 59) and binds to uPAR independently of whether the receptor is occupied by uPA, and MAb R3 recognizes the ligand-binding domain of uPAR (residues 1-87) and inhibits uPA binding (36, 58, 59 ). Polyclonal rabbit anti-uPA antibodies were prepared as described elsewhere and used as purified IgG (43, 45, 60) . Anti-vinculin rabbit serum was a gift from Dt. Ismo Virtanen. University of Helsinki. Rabbit antisera against human vitronectin (VN), human vitronectin receptor (VNR) (a&). and human fibronectin receptor (FNR), and murine MAb to the human integrin subunits a2 and a3
were from Telios (La Jolla, CA). Rabbit antibodies to mouse laminin were from Gibco, and protein A-purified MAb to human thrombospondin were kindly provided by Dr. Deane F. Mosher, University of Wisconsin. Perlecan (basement membrane-associated heparan sulfate proteoglycan) was studied with a pool of four different MAb (3M8, 481, 9C9, and 9M7; 100 hg each per ml) (61), which were a kind gift from Dr. Guido David, Leuven, Belgium. Rabbit antibodies to human fibronectin (FN), mouse MAb specific to an intracellular antigen of human macrophages (CD-68). mouse MAb IgGl to biotin, rabbit immunoglobulins to human thyroglobulins, and fluorescein isothiocyanate (F1TC)-conjugated rabbit anti-mouse immunoglobulins were from Dakopatts (Glostmp, Denmark). Highly purified rhodamine (TRIX)-conjugated affinity-purified donkey anti-mouse IgG and FIX-conjugated affinity-purified donkey anti-rabbit IgG were from Jackson Immunoresearch Laboratories (West Grove, PA).
Immunofluorescence Microscopy. A procedure in which live cells were exposed to the primary antibodies at N O T before any fixation was found optimal for staining of uPAR. Coverslip cultures of cells were washed three times for 1 min with Dulbecco's PBS (137 mM NaCI, 2.7 mM KCI, 8 mM NazHP04, 1.5 mM KHzP04, 0.9 mM CaC12, 0.5 mM MgC12 ~H z O , pH 7.4) supplemented with 0.2% BSA (DPBS-BSA) at -0°C. The cells were incubated with the primary antibodies diluted in DPBS-BSA MAb antiuPAR R4 at 1:10 and anti-uPA clone 12 at 1:40 (14 pg/ml), polyclonal rabbit anti-uPA at 1:150, anti-VNR at 1:150, anti-VN at 1:200, anti-laminin at 1:40, antibodies to a2 and a3 integrin subunits at l:lO, antibodies to FNR at 1:100, anti-FN at 1:50, anti-thrombospondin at 1:20, and antiperlecan MAb at 1:5 (20 yg/ml each) for 30 min at -0'C. The cell layers were then washed briefly four or five times with ice-cold DPBS-BSA and fixed with pre-cooled methanol at -20°C for 15 min. For matrix components and integrins the cells were pre-fixed with methanol for 15 min at -2O'C. As controls we used MAb to biotin and to macrophage CD68 and polyclonal anti-thyroglobulin, diluted at 1:5, 1:10, and 1:300, respectively, to give antibody concentrations comparable to those of the specific antibodies, applied for 30 min at N O T . After that the cells were rinsed three times for 1 min with DPBS-BSA and treated for 30 min with FITCconjugated secondary antibodies diluted at 1:60.
For double-immunofluorescence staining with MAb to uPAR-R4 and with polyclonal antibodies to VNR or to vinculin, the cultured RD cell layers were washed three times for 1 min with cold DPBS-BSA and then incubated with the uPAR antibodies diluted 1:10 for 30 min at -0 C The cells were washed with cold DPBS and fixed with pre-cooled methanol for 15 min at -20°C. After rinsing, the staining procedure was carried out with antibodies in the following sequence: TRITC-conjugated donkey anti-mouse IgG (1:80), rabbit anti-human VNR antibodies (1:lSO) or polyclonal rabbit anti-vinculin serum (1:150), and FIX-conjugated donkey anti-rabbit IgG (1:80). As controls we used mouse anti-biotin and rabbit anti-human thyroglobulin, diluted 1:10 and 1:300, respectively, and also omissions of each antibody in the staining procedure. After rinsing with DPBS-BSA the specimens were mounted in glycerol/Na-barbital mounting medium (pH 8) containing 15 mM P-mercaptoethanol. They were viewed with an Olympus BH2-RFL microscope (Tokyo, Japan) equipped with a 100-W mercury lamp, dichroic mirror BH2-DMBG, exciter filter BP-490, and barrier filter DM-580 (0-590) with supplementary exciter filter E-455 (for fluorescein). For rhodamine exciter filter BP-545 was used.
Antibody-induced Clustering. RD and HES cells weregrown on coverslips in 24-well plates with medium and serum (see above). Cells were seqded on the same day ot 1 day before experiments. RD and HES cells were treated with high molecular weight uPA 10 IU/ml (#124; American Diagnostica, Greenwich, CT) in serum-containing medium for 1 hr at 37'C or left untreated. The cells were placed on ice and washed three times for 1 min with ice-cold DPBS-BSA (0.5%) and treated for 30 min with primary mouse antibodies to uPAR (R4 or R3), mouse anti-uPA (clone 12) or, as a control antibody, mouse anti-biotin diluted in DPBS-BSA 1:lO. 1:40, and l:lO, respectively. The secondary antibody was affinity-purified rabbit anti-mouse IgG diluted 1:100 (12.7 pg/ml) in DPBS-BSA, incubated for 15 min at either 37°C or -0°C. As a control the secondary antibody was replaced with the same volume of diluent (DPBS-BSA). Cell layers were fixed with methanol for 15 min at -20'C and treated for 30 min with FITC-conjugated swine anti-rabbit or rabbit anti-mouse IgG diluted 1:60 in DPBS-BSA. Finally, the samples were mounted for microscopy (see above).
Immunofenitin Electron Microscopy. Fixation-immunolabeling protocols were first evaluated using various concentrations of paraformaldehyde and/or glutaraldehyde (EM grade) (Leiras; Turku, Finland). Freshly dissolved 0.5% sodium borohydride (NaBH4) (Sigma; St Louis, MO) in DPBS was applied after glutaraldehyde-containing pre-fixatives. Cultured RD cells were rinsed briefly three times with ice-cold DPBS-BSA, incubated with the primary antibodies (MAb anti-uPAR-R4 or anti-CD68 and as control 
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Results
Distribution of uPAR and uPA
Extracellular binding of uPAR antibodies was best visualized at the LM level when the cells were treated with the primary antibodies at w0"C and then fixed with methanol at -20°C. Staining with uPAR-R4 monoclonals, which recognize both unoccupied and occupied receptors, occurred at the surfaces of RD and HES cells and was concentrated at the focal contacts (Figures la and lb) , as also shown for uPA in Figure 1h . In addition, HES cells showed diffuse staining for uPAR on all cell surfaces (Figures 1b and 3a) . In double immunofluorescence, uPAR was largely co-localized with vinculin ( Figures IC and Id) . In migrating cells uPAR could be seen as spots or lengthy striae left behind by the cells on the substratum (Figure le) . On RD cells uPAR was found at cell peripheries and especially localized at cell-cell adhesion contact sites ( Figure If) : there was an apparently continuous line of uPAR immunofluorescence between such adjacent adhering cells. However, there was also staining along the entire cell. On HES cells, comparable distinct labeling for uPAR or uPA of the cell-cell contact sites was not seen, in agreement with the observation that fibroblasts do not form intimate cell-cell contacts (62). On HES cells (Figure 1b ) uPAR staining gave a more extended and finer fibrillar pattern at the focal contacts than on RD cells (Figure la) .
Matrix Components and Integrins on RD Cells
In search for molecule(s) that would co-localize with uPAR, we used antibodies to various pericellular matrix components [laminin, basement membrane-associated heparan sulfate proteoglycan (perlecan), VN, thrombospondin, FN] and several integrins (VNR, FNR, and the a2 and a3 integrin subunits) at the immunofluorescence level. Staining was carried out both on live RD cells in the cold and after pre-fiition with methanol. The pre-fixation method gave clearer results for integrins. In double immunofluorescence studies only the VNR (a& integrin) was found at the same locations as uPAR. However, within the focal adhesions uPAR (Figure 2a ) was more peripherally located than VNR (Figure 2b ).
Antibody-induced Clustering
We were interested in determining whether free uPAR and the uPAR-uPA complex were laterally mobile. HES and RD cells were chosen because they have different amounts of uPA on the cell surface (10, 43) . Antibody-induced clustering experiments were carried out by treating the cells first with the primary antibody at -0°C and then the secondary antibody (rabbit anti-mouse IgG) at either 37°C or -0°C. The control cells treated with DPBS-BSA (in place of secondary antibodies) showed no clustering (HES in Figures  3a and 3c and RD in Figures 3e and g ). The secondary antibcdies clustered both the receptors and their ligand at 37°C (HES in Figures   3b and 3d and RD in Figures 3f and 3h ). Even at -0°C some clustering was seen during prolonged (>30 min) incubation (data not shown). The clusters had on the cell surface a punctate pattern with clearance of diffuse staining from the cell surface. uPAR-R4 antibodies (recognizing both free and occupied receptors), which gave prominent staining especially at focal contacts, produced clustering at the focal contacts of both RD and HES cells (Figures 3b and   3f ). Clustering could be seen within focal contacts.
On HES cells uPAR-R4 antibody staining was seen both at the focal contacts and diffusely on the cell surface (Figure 3a) , whereas uPAR-R3 antibodies (recognizing unoccupied receptors) showed homogeneous staining (Figures 3c and 4a) . The R3 antibodies, followed by the secondary antibody, clustered the free uPAR more effectively (Figure 3d ) than did the R4 antibodies (Figure 3b ). On RD cells R3 gave weak or no staining, suggesting that on these cells uPAR was predominantly occupied.
By immunofluorescence we could barely detect any uPA on HES cells (Figure 4c ), in agreement with previous reports (10, 43) . However, after saturation of HES cell surfaces with exogenous uPA, antiuPA showed distinct staining at the focal contacts (Figure 4d ). In such uPA-treated cells uPAR-R3 antibody gave almost no reaction (Figure 4b) . A summary of the observed staining patterns is presented in Table 1 .
Immunoelectron Microscopy of uPAR
RD cells and R4 antibodies (recognizing both occupied and unoccupied receptors) were used for localization of uPAR. We found uPAR-R4 staining at cell-cell contacts (Figure sa) and along (not shown) and at the tips of microspikes (Figure 5b ). Some clusters were also found all over the cell surface. In the controls only occasional ferritin grains were seen (data not shown). Omission of any of the test antibodies in the procedure yielded negative staining.
Discussion
We have localized uPAR on RD sarcoma cells and HES fibroblasts and have also compared the distribution of uPAR to those of several matrix and adhesion proteins (FN, VN, perlecan, thrombospondin and laminin) and certain integrins (VNR, FNR, and the a2 and a3 integrin subunits) on RD cells.
Like pro-uPA and activated uPA earlier (43-46), anti-uPAR antibodies (clone R4) that recognize both uPA-occupied and -unoccupied receptors labeled uPAR in the focal adhesions of RD and HES cells. Double-immunofluorescence staining confirmed that the occupied uPAR (stained with the R4 antibodies) at the focal contacts of RD cells is largely co-localized with vinculin. The monoclonal R3-uPAR antibodies, which have the same binding site as uPA and are thus able to bind to the free receptor only (36,58,59), reacted very weakly with RD cells but gave strong diffuse staining all over HES cell surfaces, with no enrichment at focal adhesions.
We interpret these results to mean that on RD cells uPAR is predominantly occupied and confined to the cell adhesion sites, whereas on HES cells uPAR is largely unoccupied and diffusely distributed. This conclusion is supported by observations on the effect of exogenous uPA added to HES cells, which led to uPA staining at focal contacts, concomitant with a loss of the diffusely distributed uPAR. In actively growing normal fibroblasts uPA is found at the focal adhesions only and is absent from quiescent cultures (45).
We also showed by clustering experiments that free uPAR (detected by R3 antibodies) and, to a limited extent, occupied uPAR (detected in the focal adhesions with R4 but not with R3 antibod- (1) the primary uPAR-R~ antibodies and (h) anti-uPA antibodies; RD cells. The clustering effect is limited with uPAR-R~ and anti-uPA antibodies and occurs within focal adhesions; the stria-like pattern (a,e.g) is converted to "strings of pearls" (b,f.h). This is seen for both uPAR (bJ) and uPA (h). In contrast, uPAR-R3 antibodies gave diffuse staining (c) and were clustered by secondary antibodies (d). These clusters were homogeneously distributed as dots on HES cells. Bars = 10 pm. ies), were able to move on the cell surface. Such lateral mobility of free receptors was best seen at 37°C. but some mobility was evident even after prolonged incubation in the cold. The mobility of occupied receptors, detected with R4 antibodies in focal adhesions of RD cells, was limited. Nevertheless, after incubations at 37"C, some of the uPAR and uPA was found in clusters, within the focal adhesions and also elsewhere on the cell surface.
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We found the live-staining procedure optimal for detection of cell surface uPAR. It should be noted that the IF procedure involved incubation with the primary antibodies and washes for 30 min at -0°C. Although some lateral mobility may have occurred during the (primary antibody) IF procedure, its effect must have been of little significance, considering the fact that even with the precipitating (secondary) antibodies prolonged treatments were required to achieve observable redistribution in the cold.
The lateral diffusion of several GPI-anchored proteins has previously been characterized (63-67). Some GPI-anchored proteins have restricted lateral mobility and there are variations in the size of the mobile fractions (65,67). From such findings it has been proposed that restricted diffusion is due to interactions of the extracellular domain of the GPI-anchored protein. In our experiments, antibody-induced clustering suggested that unoccupied uPAR was quite freely mobile in the plane of the membrane at 37"C, whereas the occupied uPAR showed only restricted lateral mobility from 
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